1. 399 Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial. (10th December 2020) Authors: Harris, Dean; Brungs, Daniel; Ladwah, Rahul; Mant, Andrew; McGrath, Margaret; Tazbirkova, Andrea; Akopov, Andrey; Fadeeva, Natalia; Kasparov, Boris; Kovalenko, Nadezhda; Kozlov, Vadim; Moiseenko, Fedor; Oschepkov, Vasiliy; Koralewski, Piotr; Kowalski, Dariusz; Lugowska, Iwona; Charoentumn, Chaiyu... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 399 Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial. (9th November 2020) Authors: Harris, Dean; Brungs, Daniel; Ladwah, Rahul; Mant, Andrew; McGrath, Margaret; Tazbirkova, Andrea; Akopov, Andrey; Fadeeva, Natalia; Kasparov, Boris; Kovalenko, Nadezhda; Kozlov, Vadim; Moiseenko, Fedor; Oschepkov, Vasiliy; Koralewski, Piotr; Kowalski, Dariusz; Lugowska, Iwona; Charoentumn, Chaiyu... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma. (December 2019) Authors: Qin, Shukui; Chan, Stephen Lam; Sukeepaisarnjaroen, Wattana; Han, Guohong; Choo, Su Pin; Sriuranpong, Virote; Pan, Hongming; Yau, Thomas; Guo, Yabing; Chen, Minshan; Ren, Zhenggang; Xu, Jianming; Yen, Chia-Jui; Lin, Zhong-Zhe; Manenti, Luigi; Gu, Yi; Sun, Yongjian; Tiedt, Ralph; Hao, Lu; Song, We... Journal: Therapeutic advances in medical oncology Issue: Volume 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial. Issue 10274 (13th February 2021) Authors: Sezer, Ahmet; Kilickap, Saadettin; Gümüş, Mahmut; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Turk, Haci M; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Clingan, Philip; Sriuranpong, Virote; Rizvi, Naiyer; Gao, Bo; Li, Siyu; Lee, Sue; McGuire, Kristina; Chen, Chieh-I; Makharadze,... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial. (August 2021) Authors: Rugo, Hope S.; Pennella, Eduardo J.; Gopalakrishnan, Unmesh; Hernandez-Bronchud, Miguel; Herson, Jay; Koch, Hans Friedrich; Loganathan, Subramanian; Deodhar, Sarika; Marwah, Ashwani; Manikhas, Alexey; Bondarenko, Igor; Parra, Joseph D.; Abesamis-Tiambeng, Maria Luisa T.; Akewanlop, Charuwan; Vynn... Journal: Breast Issue: Volume 58(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open‐label, single‐arm phase II study. Issue 3 (9th May 2014) Authors: Srimuninnimit, Vichien; Sriuranpong, Virote; Suwanvecho, Suthida Journal: Asia-Pacific journal of clinical oncology Issue: Volume 10:Issue 3(2014:Sep.) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma. Issue 3 (21st March 2017) Authors: Lertbutsayanukul, Chawalit; Tharavej, Chadin; Klaikeaw, Naruemon; Prayongrat, Anussara; Lowanitchai, Chutinan; Sriuranpong, Virote Journal: Thoracic cancer Issue: Volume 8:Issue 3(2017) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IDDF2019-ABS-0171 EUS-Guided radiofrequency ablation as adjunctive treatment for unresectable pancreatic cancer versus chemotherapy alone (ERAP). (June 2019) Authors: Tiankanon, Kasenee; Kongkam, Pradermchai; Luangsukrerk, Thanawat; Sriuranpong, Virote; Nantavithya, Chonnipa; Jantarattana, Trirat; Canones, Arlyn; Angsuwatcharakon, Phonthep; Ridtitid, Wiriyaporn; Kullavanijaya, Pinit; Rerknimitr, Rungsun Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study. (October 2022) Authors: Teeyapun, Nattaya; Luangdilok, Sutima; Pakvisal, Nussara; Sainamthip, Panot; Mingmalairak, Siyamol; Poovorawan, Nattaya; Sitthideatphaiboon, Piyada; Parinyanitikul, Napa; Sriuranpong, Virote; Namkanisorn, Teerayuth; Inthasuwan, Pratchaya; Angspatt, Pattama; Wongchanapat, Ploytuangporn; Bamrungnam... Journal: EClinicalMedicine Issue: Volume 52(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4. (November 2022) Authors: Xu, Binghe; Hu, Xichun; Li, Wei; Sun, Tao; Shen, Kunwei; Wang, Shusen; Cheng, Ying; Zhang, Qingyuan; Cui, Shude; Tong, Zhongsheng; Geng, Cuizhi; Song, Erwei; Huang, Chiun-Sheng; Sriuranpong, Virote; Ngan, Roger K.C.; Chia, Yee H.; Wang, Xinwei; Zhao, Huadong Journal: European journal of cancer Issue: Volume 175(2022) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗